← Back to all trials
Enrolling By Invitation
NCT04930289
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
Conditions: Interstitial Lung Disease, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Emphysema
Sex: All
Healthy volunteers: No
Enrollment: 3500
Sponsor: Paragonix Technologies
Location: St. Joseph's Hospital and Medical Center Phoenix Arizona
Summary
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients
Eligibility Criteria
Inclusion Criteria:
* Donor and donor lungs matched to the prospective recipient based upon institutional medical practice
* Registered male or female primary lung transplant candidates including pediatric candidates
Exclusion Criteria:
* Donor and donor lungs that do not meet institutional clinical requirements for transplantation
* Patients who are incarcerated persons (prisoners)
* Patients who have had a previous major organ transplant (heart, lungs, liver, kidney, pancreas)
* Patients who are receiving multiple organ transplants
Source: ClinicalTrials.gov (NCT04930289). StuddyBuddy aggregates publicly available trial information.
